Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas

British Journal of Cancer

Volumn 74, Issue 2, 1996, Pages 187-193

  Kaaijk, P ^a,b   Troost, D ^a   De Boer, O J ^a   Van Amstel, P ^a   Bakker, P J M ^a   Leenstra, S ^a   Bosch, D A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Brain neoplasm; Glioma; Image analysis; Multidrug resistance; Organ culture

Indexed keywords

CARMUSTINE; CYTOSTATIC AGENT; DAUNORUBICIN; DOXORUBICIN; GLYCOPROTEIN P; LIPOSOME; POLYMER;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRATUMORAL DRUG ADMINISTRATION; MULTICELLULAR SPHEROID; MULTIDRUG RESISTANCE; PHARMACEUTICS; PRIORITY JOURNAL;

EID: 0030035989     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.336     Document Type: Article

References (25)

1. BJERKVIG R, TØNNESEN A, LAERUM OD AND BACKLUND E-O. (1990). Multicellular tumor spheroids from human gliomas maintained in organ culture. J. Neurosurg., 72, 463-475.
2. BRADLEY G, JURANKA PF AND LING V. (1988). Mechanism of multidrug resistance. Biochim. Biophys. Acta, 948, 87-128.
3. BREM H, MAHALEY SM, VICK NA, BLACK KL, SCHOLD SC, BURGER PC, FRIEDMAN AH, CIRIC IS, ELLER TW, COZZENS JW AND KENEALY JN. (1991). Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J. Neurosurg., 74, 441-446.
4. COLE SPC, BHARDWAJ G, GERLACH JH, MACKIE JE, GRANT CE, ALMQUIST KC, STEWART AJ, KURZ EU, DUNCAB AMV AND DEELEY RG. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
5. COLE SPC, SPARKS KE, FRASER K, LOE DW, GRANT CE, WILSON GM AND DEELEY RG. (1994). Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res., 54, 5902-5910.
6. DEFFIE AM, ALAM T, SENEVIRATNE C, BEENKEN SW, BATRA JK, SHEA TC, HENNER WD AND GOLDENBERG GJ. (1988). Multi-factorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and resistant P388 leukemia. Cancer Res., 48, 3595-3602.
7. EDWARDS MS, LEVIN VA AND WILSON CB. (1980). Brain tumor chemotherapy: An evaluation of agents in current use for phase I and II trials. Cancer Treat. Rep., 64, 1179-1204.
8. FORSSEN EA, COULTER DM AND PROFFITT RT. (1992). Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res., 52, 3255-61.
9. HOLST VON H, KNOCHENHAUER E, BLOMGREN H, COLLINS VP, EHN L, LINDQUIST M, NORÉN G AND PETERSON C. (1990). Uptake of adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas. Acta Neurochir., 104, 13-16.
10. KAAIJK P, TROOST D, DAS PK, LEENSTRA S AND BOSCH DA. (1995). Long-term culture of organotypic multicellular spheroids: a good alternative for studying gliomas. Neuropathol. Appl. Neurobiol., 21, 386-391.
11. KELLEY SL, BASU A, TEICHER BA, HACKER MP, HAMER DH AND LAZO JS. (1988). Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241, 1813-1815.
12. KIMMEL DW, SHAPIRO JR AND SHAPIRO WR. (1987). In vitro drug sensitivity testing in human gliomas. J. Neurosurg., 66, 161-171.
13. KLEIHUES P, BURGER PC AND SCHEITHAUER BW. (1993). Histological typing of tumours of the central nervous system. In World Health Organization International Histological Classification of Tumours, 2nd edn. Springer: Berlin.
14. KORNBLITH PL, AND WALKER M. (1988). Chemotherapy for malignant gliomas. J. Neurosurg., 68, 1-17.
15. LESSER GJ, AND GROSSMAN S. (1994). The chemotherapy of high-graded astrocytomas. Semin. Oncol., 21, 220-235.
16. LEVIN VA, HOFFMAN AND WEINKAM RJ. (1978). Pharmocokinetics of BCNU in man: a preliminary study of 20 patients. Cancer Treat. Rep., 62, 1305-1312.
17. SAEZ RJ, CAMPBELL RJ AND LAWS ER. (1977). Chemotherapeutic trials in human malignant astrocytomas in organ culture. J. Neurosurg., 46, 320-327.
18. SCHEPER RJ, BULTE JWM, BRAKKEE JGM, QUAK JJ, VAN DER SCHOOT E, BALM AJM, MEIJER CJLM, BROXTERMAN HJ, KUIPER CM, LANKELMA J AND PINEDO HM. (1988). Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multidrug-resistance. Int. J. Cancer, 42, 389-394.
19. SCHOTT B AND ROBERT J. (1989). Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells. Biochem. Pharmacol., 38, 167-72.
20. TANAKA Y, ABE Y, TSUGU A, TAKAMIYA Y, AKATSUKA A, TSURUO T, YAMAKAZI H, UEYAMA Y, SATO O, TAMAOKI N AND NAKAMURA M. (1994). Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gilomas. Virch. Arch., 425, 133-138.
21. WALKER MD, ALEXANDER E, HUNT WE, MACCARTY CS, MAHALEY MS, MEALEY J, NORRELL HA, OWENS G, RANSOHOFF J, WILSON CB, GEHAN EA, AND STRIKE TA. (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J. Neurosurg., 49, 333-343.
22. WALKER MD, GREEN SB, BYAR DP, ALEXANDER E, BATZDORF U, BROOKS WH, HUNT WE, MACCARTY CS, MAHALEY MA, MEALEY J, OWENS G, RANSOHOFF J, ROBERTSON JT, SHAPIRO WR, SMITH KR, WILSON CB AND STRIKE TA. (1980). Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant gliomas after surgery. N. Engl. J. Med., 303, 1323-1329.
23. WESTPHAL M, HANSEL M, NAUSCH H, ROHDE E, KOPPEN J, FIOLA R, HÖLZEN F AND HERRMANN H-D. (1988). Glioma biology in vitro: goals and concepts. Acta Neurochir., 43 (suppl.), 107-113.
24. YUNG WKA. (1989). In vitro chemosensitivity testing and its clinical application in human gliomas. Neurosurg. Rev., 12, 197-203.
25. YUNG WKA, SHAPIRO JR AND SHAPIRO WR. (1982). Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res., 42, 992-998.